The evaluation of the value of human recombinant thyrotropin administration for the patients with differentiated thyroid cancer during thyroid hormone withdrawal preparation for high dose radioiodine treatment.

被引:0
|
作者
Cha, J. [1 ]
Kang, W. [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Dept Nucl Med, Coll Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0593
引用
收藏
页码:S665 / S666
页数:2
相关论文
共 50 条
  • [1] Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
    Pitoia, Fabian
    Marlowe, Robert J.
    Abelleira, Erika
    Faure, Eduardo N.
    Bueno, Fernanda
    Schwarzstein, Diego
    Julio Lutfi, Ruben
    Niepomniszcze, Hugo
    [J]. JOURNAL OF THYROID RESEARCH, 2012, 2012
  • [2] Average length of hospitalization of patients with differentiated thyroid cancer treated with radioiodine: preparation with thyroid hormone withdrawal versus recombinant thyrotropin
    Montellano Fenoy, A. J.
    Sanchez Catalicio, J.
    Villena Garcia, A. C.
    Perez Angel, F.
    Murcia Durendez, M. J.
    Castellon Sanchez, M. I.
    Gallego Peinado, M.
    Salem, L. M.
    Frutos Esteban, L.
    Navarro Fernandez, J. L.
    Nicolas Ruiz, F.
    Sanz Garcia, D.
    Claver Valderas, M. A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S432 - S432
  • [3] Recombinant human thyrotropin versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer: Experience in a South Taiwanese medical center
    Tsai, Jia-Ruei
    Wu, Shu-Ting
    Chi, Shun-Yu
    Yang, Yi-Ting
    Chan, Yi-Chia
    Lim, Lay San
    Chiew, Yvonne Ee Wern
    Chen, Wen-Chieh
    Chen, Yung-Nien
    Chou, Chen-Kai
    [J]. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2023, 39 (02): : 175 - 181
  • [4] Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis
    Fu, H.
    Ma, C.
    Tang, L.
    Wu, F.
    Liu, B.
    Wang, H.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 59 (01): : 121 - 128
  • [5] Effects of Thyroid Hormone Withdrawal and Recombinant Human Thyrotropin on Glomerular Filtration Rate During Radioiodine Therapy for Well-Differentiated Thyroid Cancer
    Coura-Filho, George Barberio
    Willegaignon, Jose
    Buchpiguel, Carlos Alberto
    Sapienza, Marcelo Tatit
    [J]. THYROID, 2015, 25 (12) : 1291 - 1296
  • [6] Comparison of Therapeutic Efficacy and Clinical Parameters Between Recombinant Human Thyroid Stimulating Hormone and Thyroid Hormone Withdrawal in High-Dose Radioiodine Treatment with Differentiated Thyroid Cancer
    Choi S.
    Na C.J.
    Kim J.
    Han Y.-H.
    Kim H.-K.
    Jeong H.-J.
    Sohn M.-H.
    Lim S.T.
    [J]. Nuclear Medicine and Molecular Imaging, 2015, 49 (2) : 115 - 121
  • [7] Recombinant human thyrotropin preparation for adjuvant radioiodine treatment in children and adolescents with differentiated thyroid cancer
    Handkiewicz-Junak, Daria
    Gawlik, Tomasz
    Rozkosz, Jozef
    Puch, Zbigniew
    Michalik, Barbara
    Gubala, Elzbieta
    Krajewska, Jolanta
    Kluczewska, Aneta
    Jarzab, Barbara
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 173 (06) : 873 - 881
  • [8] Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma
    Robbins, RJ
    Tuttle, RM
    Sharaf, RN
    Larson, SM
    Robbins, HK
    Ghossein, RA
    Smith, A
    Drucker, WD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02): : 619 - 625
  • [9] Radioiodine Treatment of Metastatic Thyroid Cancer: Relative Efficacy and Side Effect Profile of Preparation by Thyroid Hormone Withdrawal Versus Recombinant Human Thyrotropin
    Klubo-Gwiezdzinska, Joanna
    Burman, Kenneth D.
    Van Nostrand, Douglas
    Mete, Mihriye
    Jonklaas, Jacqueline
    Wartofsky, Leonard
    [J]. THYROID, 2012, 22 (03) : 310 - 317
  • [10] Comparisons between Thyroid Hormone Withdrawal and Recombinant Human Thyroid-stimulating Hormone Administration for Radioiodine Ablation in Patients with Intermediate-risk to High-risk Differentiated Thyroid Cancer
    Iizuka, Y.
    Katagiri, T.
    Ogura, K.
    Inoue, M.
    Nakamura, K.
    Mizowaki, T.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S141 - S141